StockIQpro
NASDAQ:EXEL

Exelixis, Inc.

Exelixis, Inc.'s revenue grew 7.0% in fiscal 2025 to $2.3B while operating margin rose to 37.6%. Free cash flow was $875.8M, 37.7% of revenue, and the diluted share count fell 4.8%.Summary generated from Exelixis, Inc.'s SEC filings. Latest annual report filed Feb 10, 2026.

Revenue (FY25)$2.3B
Revenue growth+7.0%
Revenue, 5-yr CAGR+18.6%
Gross margin96.4%
Operating margin37.6%
Net margin33.7%
ROICn/a
Return on equity35.5%
Debt / equityn/a
Free cash flow$875.8M
FCF margin37.7%
Share count change−4.8%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue1,4351,6111,8302,1692,320
Operating income287201171605872
Net income231182208521783
Free cash flow347335293672876

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)